NCT02879981 - A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 10, 2016

Primary Completion Date

August 28, 2017

Study Completion Date

August 28, 2017

Conditions

Bronchitis

Interventions

DRUG

Guaifenesin

Administration of treatment will be according to treating physician's recommendation under local labeling. The study protocol does not specify any treatment regimen.

DRUG

Sulfamethoxazole

Administration of treatment will be according to treating physician's recommendation under local labeling. The study protocol does not specify any treatment regimen.

DRUG

Trimethoprim

Administration of treatment will be according to treating physician's recommendation under local labeling. The study protocol does not specify any treatment regimen.

Trial Locations (3)

27

Clínica Anglo Americana-CENTRO DE INVESTIGACION PEDIATRIA CAA, San Isidro

15033

Hospital Emergencias Pediatricas; Unidad de Investigación Pediátrica, La Victoria

Lima 41

Clinica Internacional, Sede San Borja; Unidad de Investigacion de Clínica Internacional, Lima

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY